JP2024542142A5 - - Google Patents

Info

Publication number
JP2024542142A5
JP2024542142A5 JP2024526902A JP2024526902A JP2024542142A5 JP 2024542142 A5 JP2024542142 A5 JP 2024542142A5 JP 2024526902 A JP2024526902 A JP 2024526902A JP 2024526902 A JP2024526902 A JP 2024526902A JP 2024542142 A5 JP2024542142 A5 JP 2024542142A5
Authority
JP
Japan
Prior art keywords
bispecific antibody
mutation
region
mutations
domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526902A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024542142A (ja
Filing date
Publication date
Priority claimed from GBGB2204539.7A external-priority patent/GB202204539D0/en
Priority claimed from GBGB2212801.1A external-priority patent/GB202212801D0/en
Application filed filed Critical
Priority claimed from PCT/EP2022/080860 external-priority patent/WO2023079101A2/en
Publication of JP2024542142A publication Critical patent/JP2024542142A/ja
Publication of JP2024542142A5 publication Critical patent/JP2024542142A5/ja
Pending legal-status Critical Current

Links

JP2024526902A 2021-11-05 2022-11-04 新規ポリペプチド Pending JP2024542142A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB2115925.6 2021-11-05
GB202115925 2021-11-05
GB2204539.7 2022-03-30
GBGB2204539.7A GB202204539D0 (en) 2022-03-30 2022-03-30 Novel peptides
GBGB2212801.1A GB202212801D0 (en) 2022-09-02 2022-09-02 Novel peptides
GB2212801.1 2022-09-02
PCT/EP2022/080860 WO2023079101A2 (en) 2021-11-05 2022-11-04 Novel polypeptides

Publications (2)

Publication Number Publication Date
JP2024542142A JP2024542142A (ja) 2024-11-13
JP2024542142A5 true JP2024542142A5 (cg-RX-API-DMAC7.html) 2025-11-13

Family

ID=84329469

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024526902A Pending JP2024542142A (ja) 2021-11-05 2022-11-04 新規ポリペプチド
JP2024526901A Pending JP2024543043A (ja) 2021-11-05 2022-11-04 新規ペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024526901A Pending JP2024543043A (ja) 2021-11-05 2022-11-04 新規ペプチド

Country Status (9)

Country Link
US (4) US20260001961A1 (cg-RX-API-DMAC7.html)
EP (2) EP4426733A2 (cg-RX-API-DMAC7.html)
JP (2) JP2024542142A (cg-RX-API-DMAC7.html)
KR (2) KR20240099410A (cg-RX-API-DMAC7.html)
AU (1) AU2022381977A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237463A1 (cg-RX-API-DMAC7.html)
IL (1) IL312556A (cg-RX-API-DMAC7.html)
MX (1) MX2024005508A (cg-RX-API-DMAC7.html)
WO (2) WO2023079102A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20260001961A1 (en) * 2021-11-05 2026-01-01 Alligator Bioscience Ab Novel polypeptides
JP2026515781A (ja) * 2023-04-13 2026-05-19 アリゲーター・バイオサイエンス・アーベー 併用療法
CN117924468B (zh) * 2023-12-08 2024-09-20 南京大学 一种靶向登革热病毒ns1蛋白纳米抗体的制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
LT2691417T (lt) 2011-03-29 2018-10-25 Roche Glycart Ag Antikūno fc variantai
GB201115280D0 (en) * 2011-09-05 2011-10-19 Alligator Bioscience Ab Antibodies, uses and methods
CA2980189A1 (en) * 2015-04-24 2016-10-27 Genentech, Inc. Multispecific antigen-binding proteins
CA3049791A1 (en) * 2017-01-27 2018-08-02 Silverback Therapeutics, Inc. Tumor targeting conjugates and methods of use thereof
EP3898681A2 (en) * 2018-12-17 2021-10-27 Alligator Bioscience AB Polypeptides
GB201820556D0 (en) 2018-12-17 2019-01-30 Alligator Bioscience Ab Novel polypeptides
AU2020357944A1 (en) * 2019-09-30 2022-03-31 Adimab, Llc CH1 domain variants engineered for preferential light chain pairing and multispecific antibodies comprising the same
EP4048701A4 (en) 2019-10-23 2024-05-29 Lyvgen Biopharma Holdings Limited Anti-cd40 binding molecules and bi-specific antibodies comprising such
KR20220147583A (ko) * 2020-01-09 2022-11-03 바이오뮤넥스 파마슈티컬스 Mait 및 종양 세포 둘 모두에 결합하는 다중특이적 항체
US20260001961A1 (en) * 2021-11-05 2026-01-01 Alligator Bioscience Ab Novel polypeptides

Similar Documents

Publication Publication Date Title
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
US11623962B2 (en) Anti-OX40 binding proteins
JP2020533948A5 (cg-RX-API-DMAC7.html)
CN108348601B (zh) 与lag3结合的抗体治疗剂
RU2018100820A (ru) ГУМАНИЗИРОВАННЫЕ АНТИТЕЛА И АНТИТЕЛА С СОЗРЕВШЕЙ АФФИННОСТЬЮ ПРОТИВ FcRH5 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
JP2018527887A5 (cg-RX-API-DMAC7.html)
JP2021524267A5 (cg-RX-API-DMAC7.html)
RU2018147413A (ru) PD-L1 специфические антитела
EP3668898A1 (en) Humanized antibodies for cd3
JP2009507470A5 (cg-RX-API-DMAC7.html)
JP2023515223A5 (cg-RX-API-DMAC7.html)
RU2009126723A (ru) Антитела к ox40l
JP2021524275A5 (cg-RX-API-DMAC7.html)
AU2019233511B2 (en) Anti C-MET antibodies
JP2022540620A5 (cg-RX-API-DMAC7.html)
CN117946277A (zh) 多特异性抗体及其制备和使用方法
JP2021509274A (ja) モノクローナル抗体およびその使用法
JP2020503256A (ja) 抗cd19抗体およびそれを使用する方法
JP2023535024A5 (cg-RX-API-DMAC7.html)
JP2023547506A5 (cg-RX-API-DMAC7.html)
JP2024516098A5 (cg-RX-API-DMAC7.html)
JP2023549316A5 (cg-RX-API-DMAC7.html)
WO2023220549A1 (en) Human tumor necrosis factor alpha antibody glucocorticoid conjugates
JP2002538771A5 (cg-RX-API-DMAC7.html)
JP2021524451A (ja) 最適化済みgp41結合分子及びその使用